{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Gonzalez-Borja I"],"funding":["gobierno de navarra, doctorandos industriales","Spanish Ministry of Economy","Ministry of Science and Innovation","Instituto de Salud Carlos III","Programa INTERREG V-A España-Francia-Andorra","Universidad de Córdoba-FEDER","refbio II","Junta de Andalucía","Department of Health from the Government of Navarra","Gobierno de Navarra"],"pagination":["5993"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9739487"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["14(23)"],"pubmed_abstract":["Despite its relative low incidence, PDAC is one of the most aggressive and lethal types of cancer, being currently the seventh leading cause of cancer death worldwide, with a 5-year survival rate of 10.8%. Taking into consideration the necessity to improve the prognosis of these patients, this research has been focused on the discovery of new biomarkers. For this purpose, patients with BL and resectable disease were recruited. Serum cytokines and growth factors were monitored at different time points using protein arrays. Immune cell populations were determined by flow cytometry in peripheral blood as well as by immunohistochemistry (IHC) in tumor tissues. Several cytokines were found to be differentially expressed between the study subgroups. In the BL disease setting, two different score"],"journal":["Cancers"],"pubmed_title":["Cytokines and Lymphoid Populations as Potential Biomarkers in Locally and Borderline Pancreatic Adenocarcinoma."],"pmcid":["PMC9739487"],"funding_grant_id":["FI17/00282","BFU2016–80360-R","BIO- 0139","PID2019-105201RB-I00","UCO-202099901918904","Ref. BMK_PANC","2018-2020","BMK_PANC","008-2018"],"pubmed_authors":["Ghanem I","Goni S","Castano JP","Gonzalez-Borja I","Gallego J","Alors-Perez E","Pazo-Cid R","Hernandez-Garcia I","Alonso L","Amat I","Feliu J","Viudez A","Vera R","Fernandez-Irigoyen J","Arrazubi V","Lopez C","Perez-Sanz J"],"additional_accession":[]},"is_claimable":false,"name":"Cytokines and Lymphoid Populations as Potential Biomarkers in Locally and Borderline Pancreatic Adenocarcinoma.","description":"Despite its relative low incidence, PDAC is one of the most aggressive and lethal types of cancer, being currently the seventh leading cause of cancer death worldwide, with a 5-year survival rate of 10.8%. Taking into consideration the necessity to improve the prognosis of these patients, this research has been focused on the discovery of new biomarkers. For this purpose, patients with BL and resectable disease were recruited. Serum cytokines and growth factors were monitored at different time points using protein arrays. Immune cell populations were determined by flow cytometry in peripheral blood as well as by immunohistochemistry (IHC) in tumor tissues. Several cytokines were found to be differentially expressed between the study subgroups. In the BL disease setting, two different score","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Dec","modification":"2026-04-08T11:08:19.811Z","creation":"2024-11-09T20:34:58.896Z"},"accession":"S-EPMC9739487","cross_references":{"pubmed":["36497475"],"doi":["10.3390/cancers14235993"]}}